Back
Cellectar Biosciences Stock Predictions
Sponsored
CLRB
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
40
CLRB
Cellectar Biosciences
Last Price:
$0.26
Seasonality Move:
-2.17%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Cellectar Biosciences Stock Forecast
-
Is Cellectar Biosciences Stock Undervalued?The current Cellectar Biosciences [CLRB] share price is $0.28. The Score for CLRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cellectar Biosciences Stock Go Up Next Year?
Data Unavailable
Cellectar Biosciences Stock Rating
Data Unavailable
Cellectar Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cellectar.com
52-Week Data
52-Week High:
4.45
52-Week Low:
0.22
Prediction Charts
Market Cap:
11.4M
Price in USD:
0.28
Volume:
4.1M
Beta:
0.83
Technical Analysis
SMA50:
1.56
SMA100:
1.82
SMA200:
2.47
52-Wk Change:
-89.31%
Stock Predictions
-
Is Cellectar Biosciences stock public?Yes, Cellectar Biosciences is a publicly traded company.
-
What is the Cellectar Biosciences stock quote today?The Cellectar Biosciences stock price is 0.28 USD today.
-
How to buy Cellectar Biosciences stock online?You can buy Cellectar Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-4 | 1.48 | 1.47 | 1.48 | 1.42 |
Dec-5 | 1.49 | 1.36 | 1.49 | 1.36 |
Dec-6 | 1.37 | 1.39 | 1.41 | 1.36 |
Dec-9 | 1.39 | 1.35 | 1.39 | 1.33 |
Dec-10 | 1.35 | 1.28 | 1.37 | 1.26 |
Dec-11 | 0.43 | 0.31 | 0.46 | 0.28 |
Dec-12 | 0.30 | 0.26 | 0.31 | 0.25 |
Dec-13 | 0.26 | 0.26 | 0.27 | 0.23 |
Dec-16 | 0.27 | 0.26 | 0.27 | 0.24 |
Dec-17 | 0.25 | 0.26 | 0.28 | 0.24 |
Dec-18 | 0.26 | 0.25 | 0.27 | 0.25 |
Dec-19 | 0.25 | 0.24 | 0.25 | 0.22 |
Dec-20 | 0.24 | 0.24 | 0.25 | 0.23 |
Dec-23 | 0.24 | 0.28 | 0.28 | 0.24 |
Cellectar Biosciences Earnings
Data Unavailable
Cellectar Biosciences Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.26 per share, and an increase next year of $0.89 per share.
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.